Telomerase peptide vaccination: a phase I/II study in patients with non-small cell lung cancer.
Brunsvig PF, Aamdal S, Gjertsen MK, Kvalheim G, Markowski-Grimsrud CJ, Sve I, Dyrhaug M, Trachsel S, Møller M, Eriksen JA, Gaudernack G.
Brunsvig PF, et al.
Cancer Immunol Immunother. 2006 Dec;55(12):1553-64. doi: 10.1007/s00262-006-0145-7. Epub 2006 Feb 21.
Cancer Immunol Immunother. 2006.
PMID: 16491401
Free PMC article.
Clinical Trial.